false 0001596783 0001596783 2020-02-03 2020-02-03

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): February 3, 2020

 

CATALENT, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-36587

 

20-8737688

(State or other jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification Number)

14 Schoolhouse Road

Somerset, New Jersey

 

08873

(Address of principal executive office)

 

(Zip code)

(732) 537-6200

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

symbol(s)

 

Name of each exchange

on which registered

Common Stock, $0.01 par value per share

 

CTLT

 

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 


Item 1.01 Entry into a Material Definitive Agreement.

On February 3, 2020, Catalent, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) by and among the Company and J.P. Morgan Securities LLC and UBS Securities LLC (collectively, the “Underwriters”), relating to an underwritten offering (the “Offering”) of 9,712,837 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share, which includes up to 1,266,891 Shares which may be offered and sold upon the exercise by the Underwriters of their option to purchase additional shares of Common Stock, pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-233756), filed on September 13, 2019, as supplemented by the prospectus supplement dated February 3, 2020. Pursuant to the Underwriting Agreement, the Underwriters purchased the Shares at a price of $58.58 per share in a transaction that was completed on February 6, 2020.

The underwriting agreement includes customary representations, warranties and covenants by the Company. It also provides for customary indemnification of the Underwriters by the Company for certain liabilities, including liabilities under the Securities Act of 1933, as amended.

From time to time, in the ordinary course of their business, the Underwriters or their respective affiliates have performed, and may in the future perform, various financial advisory and investment banking services for us, for which they received or will receive customary fees and expenses. Certain of the Underwriters or their respective affiliates are agents and/or lenders under our senior secured credit facilities, for which they have received or expect to receive customary compensation. In addition, such Underwriters or their respective affiliates may receive a portion of the net proceeds of the Offering, which we are using to repay borrowings under our revolving credit facility.

The description of the Underwriting Agreement is qualified in its entirety by the terms of such agreement, which is incorporated herein by reference and attached to this report as Exhibit 1.1.

A copy of the opinion of Fried, Frank, Harris, Shriver & Jacobson LLP relating to the validity of the issuance and sale of shares of the Company’s common stock pursuant to the underwriting agreement is also filed herewith as Exhibit 5.1. The underwriting agreement and the opinion filed herewith are incorporated by reference into the above referenced registration statement on Form S-3.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit

    No.    

   

Description

         
 

  1.1

   

Underwriting Agreement, dated February 3, 2020, among the Company, J.P. Morgan Securities LLC and UBS Securities LLC.

         
 

  5.1

   

Opinion of Fried, Frank, Harris, Shriver & Jacobson LLP relating to the Common Stock.

         
 

23.1

   

Consent of Fried, Frank, Harris, Shriver & Jacobson LLP (included in Exhibit 5.1).

         
 

104

   

Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document).


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Catalent, Inc.

 

(Registrant)

     

By:

 

/s/ Steven L. Fasman

 

Steven L. Fasman

 

Senior Vice President, General Counsel

and Secretary

Date: February 6, 2020

Catalent (NYSE:CTLT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Catalent Charts.
Catalent (NYSE:CTLT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Catalent Charts.